D-0014-2020 Class II Terminated
FDA drug recall D-0014-2020 was initiated by Colonia Care Pharmacy on Jul 24, 2019 and is designated Class II. Reason for recall: Lack of Assurance of Sterility: product sterility cannot be guaranteed. The recall status is terminated (terminated Apr 5, 2023). Affected quantity: 18 vials.
Recall Details
- Product Type
- Drugs
- Report Date
- Oct 9, 2019
- Initiation Date
- Jul 24, 2019
- Termination Date
- Apr 5, 2023
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 18 vials
Product Description
C-HYDROXYPROGESTERONE CAPRO 250MG/ML INJECTION, 5 mL vial, Rx only, Colonia Care Pharmacy, 515 Inman Ave., Suite A, Colonia, N.J. 07067
Reason for Recall
Lack of Assurance of Sterility: product sterility cannot be guaranteed.
Distribution Pattern
Patient Specific Prescriptions in NJ
Code Information
Lot #: 041119A, BUD 10/08/19; 051019J, BUD 11/6/19; 070519C, BUD 01/01/20
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0014-2020
- openFDA file date
- Nov 3, 2026
- Loaded by RegDataLab
- Nov 4, 2026